Registration statement for securities of certain foreign private issuers

Consolidated Statement of Profit and Loss and Other Comprehensive Loss

v3.22.1
Consolidated Statement of Profit and Loss and Other Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Profit or loss [abstract]      
Revenue $ 322,921 $ 79,272 $ 16,034
Cost of care delivery (289,672) (67,254) (19,810)
Platform & application expenses (42,829) (38,137) (23,569)
Research & development expenses (47,534) (54,711) (51,205)
Sales, general & administrative expenses (196,673) (94,681) (84,270)
Recapitalization transaction expense (148,722)    
Operating loss (402,509) (175,511) (162,820)
Finance costs (14,291) (4,530) (1,116)
Finance income 326 610 1,015
Change in fair value of warrant liabilities 27,811    
Exchange gain / (loss) 868 (2,836) 17,075
Net finance income (expense) 14,714 (6,756) 16,974
Gain on sale of subsidiary 3,917    
Gain on remeasurement of equity interest 10,495    
Share of loss of equity-accounted investees (2,602) (1,124)  
Loss before taxation (375,985) (183,391) (145,846)
Tax benefit / (provision) 1,474 (4,639) 5,559
Loss for the financial year (374,511) (188,030) (140,287)
Other comprehensive loss Items that may be reclassified subsequently to profit or loss:      
Currency translation differences (1,702) 3,579 (9,693)
Other comprehensive gain / (loss) for the year, net of income tax (1,702) 3,579 (9,693)
Total comprehensive loss for the year (376,213) (184,451) (149,980)
Loss attributable to:      
Equity holders of the parent (368,482) (186,799) (140,287)
Non-controlling interest (6,029) (1,231)  
Loss for the financial year (374,511) (188,030) (140,287)
Total comprehensive loss attributable to:      
Equity holders of the parent (370,184) (183,220) (149,980)
Non-controlling interest (6,029) (1,231)  
Total comprehensive loss for the year $ (376,213) $ (184,451) $ (149,980)
Loss per share      
Net loss per share, Basic and Diluted $ (1.36) $ (0.77) $ (0.58)
Weighted average shares outstanding, Basic and Diluted 271,321,253 242,935,770 241,903,166